valyl-glycyl-valyl-alanyl-prolyl-glycine has been researched along with Cancer of Skin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Darvas, Z; Falus, A; Pocza, P; Süli-Vargha, H | 1 |
1 other study(ies) available for valyl-glycyl-valyl-alanyl-prolyl-glycine and Cancer of Skin
| Article | Year |
|---|---|
Locally generated VGVAPG and VAPG elastin-derived peptides amplify melanoma invasion via the galectin-3 receptor.
Topics: Antigens, Neoplasm; Biomarkers, Tumor; Carrier Proteins; Cell Adhesion; Cell Adhesion Molecules; Cell Movement; Chemokine CXCL12; Chemotaxis; Disease Progression; Elastin; Flow Cytometry; Galectin 3; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Glycoproteins; Humans; Immunohistochemistry; Matrix Metalloproteinase 2; Matrix Metalloproteinase 3; Melanoma; Neoplasm Invasiveness; Neovascularization, Pathologic; Oligopeptides; Polymerase Chain Reaction; Receptors, CXCR4; Skin Neoplasms; Tropoelastin; Vascular Endothelial Growth Factor C | 2008 |